Thus, although it is widely accepted that migrating metastatic cancer cells exhibit higher plasmin activity than cells from primary tumors, mechanisms or conditions responsible for altered PAI-1/uPA expression ratios and thus elevated plasmin activity are rather unknown (Bharadwaj et al. 2021). This evidence concerns the gene PLG and cancer.